Covid, RSV, Influenza: The 2025–26 NEJM Update 🧬🔥📊

📘 New NEJM Evidence for the 2025–26 Vaccine Season is out—and it delivers clarity at a time we need it most. The systematic review of 511 studies shows strong, consistent protection against hospitalization from Covid-19, RSV, and Influenza, with reassuring safety profiles across age groups. 💉🛡️   Key insights: improved VE for updated Covid-19 strains, high efficacy of maternal RSV vaccination and nirsevimab for infants, and solid influenza performance. 📊👶   A valuable guide for clinicians, health systems, and policymakers as we prepare for the upcoming respiratory season. 🌐🏥